Literature DB >> 21778340

Human regulatory T cells in allogeneic stem cell transplantation.

Sya N Ukena1, Sarvari Velaga, Robert Geffers, Jens Grosse, Udo Baron, Stefanie Buchholz, Michael Stadler, Dunja Bruder, Arnold Ganser, Anke Franzke.   

Abstract

GVHD is still one of the major complications after allogeneic stem cell transplantation. Whereas murine data have clearly shown the beneficial effects of regulatory T cells (Tregs) on the prevention of GVHD, data from the human system are rare. Here, we present a comparative dynamic analysis of CD4(+)CD25(hi)CD127(lo/-) Tregs from patients with and without GVHD analyzing the whole genome profile over the first 6 months after stem cell transplantation, representing the most sensitive time window for tolerance induction. The Treg transcriptome showed a high stability. However, the comparison of Treg transcriptomes from patients with and without GVHD uncovered regulated gene transcripts highly relevant for Treg cell function. The confirmative protein analyses demonstrated a significantly higher expression of granzyme A, CXCR3, and CCR5 in Tregs of immune tolerant patients. These results point to a reduced suppressive function of Tregs from GVHD patients with diminished migration capacity to the target organs.

Entities:  

Mesh:

Year:  2011        PMID: 21778340     DOI: 10.1182/blood-2011-05-352708

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  29 in total

1.  Tregs, HSCT, and acute GVHD: up close and personal.

Authors:  John Koreth; Jerome Ritz
Journal:  Blood       Date:  2013-09-05       Impact factor: 22.113

2.  Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.

Authors:  Kazuyuki Murase; Haesook T Kim; O R Gregory Bascug; Yutaka Kawano; Jeremy Ryan; Ken-ichi Matsuoka; Matthew S Davids; John Koreth; Vincent T Ho; Corey Cutler; Philippe Armand; Edwin P Alyea; Bruce R Blazar; Joseph H Antin; Robert J Soiffer; Anthony Letai; Jerome Ritz
Journal:  Haematologica       Date:  2014-05-23       Impact factor: 9.941

3.  Increased Foxp3+Helios+ Regulatory T Cells and Decreased Acute Graft-versus-Host Disease after Allogeneic Bone Marrow Transplantation in Patients Receiving Sirolimus and RGI-2001, an Activator of Invariant Natural Killer T Cells.

Authors:  Yi-Bin Chen; Yvonne A Efebera; Laura Johnston; Edward D Ball; David Avigan; Lazaros J Lekakis; Carlos R Bachier; Paul Martin; Omar Duramad; Yasuyuki Ishii; Semi Han; Yu-Jin Jung; Dana Lee; Lori Kunkel; Robert S Negrin; Jack D Bui
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-16       Impact factor: 5.742

4.  Pre-transplant donor CD4- invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease.

Authors:  M-T Rubio; M Bouillié; N Bouazza; T Coman; H Trebeden-Nègre; A Gomez; F Suarez; D Sibon; A Brignier; E Paubelle; S Nguyen-Khoc; M Cavazzana; O Lantz; M Mohty; S Urien; O Hermine
Journal:  Leukemia       Date:  2016-10-14       Impact factor: 11.528

5.  Injury-induced MRP8/MRP14 stimulates IP-10/CXCL10 in monocytes/macrophages.

Authors:  Juan Wang; Yoram Vodovotz; Liyan Fan; Yuehua Li; Zheng Liu; Rami Namas; Derek Barclay; Ruben Zamora; Timothy R Billiar; Mark A Wilson; Jie Fan; Yong Jiang
Journal:  FASEB J       Date:  2014-10-23       Impact factor: 5.191

6.  Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes.

Authors:  Wilhem Leconet; Pierre Petit; Sylvie Peraldi-Roux; Damien Bresson
Journal:  Mol Ther       Date:  2012-09-18       Impact factor: 11.454

7.  In vitro immunological effects of blocking CCR5 on T cells.

Authors:  Jing Yuan; Han-Yun Ren; Yong-Jin Shi; Wei Liu
Journal:  Inflammation       Date:  2015-04       Impact factor: 4.092

Review 8.  Homeostatic control of regulatory T cell diversity.

Authors:  Adrian Liston; Daniel H D Gray
Journal:  Nat Rev Immunol       Date:  2014-01-31       Impact factor: 53.106

9.  Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.

Authors:  Wei Li; Liangyi Liu; Aurelie Gomez; Jilu Zhang; Abdulraouf Ramadan; Qing Zhang; Sung W Choi; Peng Zhang; Joel K Greenson; Chen Liu; Di Jiang; Elizabeth Virts; Stephanie L Kelich; Hong Wei Chu; Ryan Flynn; Bruce R Blazar; Helmut Hanenberg; Samir Hanash; Sophie Paczesny
Journal:  JCI Insight       Date:  2016-05-05

10.  Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation.

Authors:  Koji Kawaguchi; Katsutsugu Umeda; Eitaro Hiejima; Atsushi Iwai; Masamitsu Mikami; Seishiro Nodomi; Satoshi Saida; Itaru Kato; Hidefumi Hiramatsu; Takahiro Yasumi; Ryuta Nishikomori; Tadakazu Kondo; Akifumi Takaori-Kondo; Toshio Heike; Souichi Adachi
Journal:  Int J Hematol       Date:  2018-03-26       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.